News

MilliporeSigma Launches AI Solution for Integrating Drug Discovery and Molecule Synthesis

December 08, 2023

MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.

Absci and AstraZeneca Collaborate on AI-Driven Oncology Candidate

December 05, 2023

AstraZeneca will utilize Absci’s AI antibody drug creation platform to create an AI-designed antibody.

FDA Warns of Rare but Serious Drug Reaction to Antiseizure Medicines

December 04, 2023

The medicines, levetiracetam and clobazam, may a cause life-threatening reaction to patients if not caught and treated quickly.

Novartis Voluntarily Recalls Two Lots of Sandimmune Oral Solution, 100 mg/mL

December 04, 2023

Novartis has issued a nationwide voluntary recall of two lots of Sandimmune Oral Solution (cyclosporine oral solution, USP), 100 mg/mL because of crystallization issues.

Falling Short

December 02, 2023

Drug shortages across Europe are being exacerbated by increased demand, struggling supply chains, and manufacturer suspensions.

Renewing the UK Voluntary Pricing Scheme

December 02, 2023

What does the 2024 VPAS mean for pharma?

Novo Nordisk to Make Multi-Billion Dollar Investment in Expansion of Production Facilities in France

December 01, 2023

Novo Nordisk will invest more than DKK 16 billion (US$2.3 billion) to expand its production facilities in Chartres, France.

New Medicines, Markets, and Manufacture: CRISPR for Sickle Cell Disease and β-thalassemia

November 30, 2023

Exagamglogene autotemcel seen as synechdoche.

TAU Systems to Establish TAU Labs, a New Laser Plasma Accelerator Application Center

November 29, 2023

TAU Systems plans to establish TAU Labs, a new next-generation, laser-driven plasma accelerator laboratory, in Carlsbad, Calif.

Genentech and NVIDIA Form AI Research Collaboration for Drug Discovery and Development

November 29, 2023

Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics.